NEW BIOTECHNOLOGICAL SYSTEMS IPSC FOR PHARMACEUTICAL DEVELOPMENT IN THE AREA OF NEURODEGENERATIVE DISEASES (Q2041388)
Jump to navigation
Jump to search
Project Q2041388 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | NEW BIOTECHNOLOGICAL SYSTEMS IPSC FOR PHARMACEUTICAL DEVELOPMENT IN THE AREA OF NEURODEGENERATIVE DISEASES |
Project Q2041388 in Italy |
Statements
1,379,705.73 Euro
0 references
2,759,411.46 Euro
0 references
50.0 percent
0 references
27 September 2016
0 references
29 November 2019
0 references
BIOREP S.R.L.
0 references
AXXAM SPA
0 references
CNR - CONSIGLIO NAZIONALE DELLE RICERCHE
0 references
UNIVERSITA' VITA-SALUTE SAN RAFFAELE
0 references
I.M.S. - ISTITUTO DI MANAGEMENT SANITARIO S.R.L.
0 references
45°32'12.05"N, 9°11'15.83"E
0 references
IL PROGETTO IPSLIGHT FOCALIZZATO SULLO SVILUPPO TECNOLOGICO DI MODELLI IPSC (INDUCED PLURIPOTENT STEM CELL) APPLICABILI ALLA RICERCA FARMACEUTICA NELLAMBITO DELLE PATOLOGIE DEGENERATIVE CRONICHE E SULLA VALIDAZIONE E APPLICAZIONE DI TALI MODELLI IN COMBINAZIONE CON METODICHE ALLAVANGUARDIA DI HIGH-CONTENT E HIGH-THROUGHPUT SCREENING UTILIZZATE PER LIDENTIFICAZIONE DI POTENZIALI FARMACI. IL FOCUS PRIMARIO SULLA PATOLOGIA DI PARKINSON (PD - PARKINSONS DISEASE), UNA MALATTIA IN RAPIDA CRE (Italian)
0 references
THE IPLIGHT PROJECT FOCUSED ON THE TECHNOLOGICAL DEVELOPMENT OF IPSC MODELS APPLICABLE TO PHARMACEUTICAL RESEARCH IN CHRONIC DEGENERATIVE DISEASES AND ON THE VALIDATION AND APPLICATION OF THESE MODELS IN COMBINATION WITH HIGH-CONTENT AND HIGH-THROUGHPUT SCREENING METHODS USED TO IDENTIFY POTENTIAL MEDICINES. THE PRIMARY FOCUS ON PARKINSON’S DISEASE (PD), A RAPID ECR DISEASE (English)
0 references
Identifiers
E76D17000120009
0 references